Replies to post #57586 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

Depends on your time frame, Bourbon. EMA approval in a year and “approvable” interim P3 data a year later—and maybe even accelerated approval—and this gets bought out for $10b easy. Good partnerships, milestones and EMA approval would mean minimal dilution, if any, to get to that point. At $10b currently that is $200 per share. Even at 100m shares outstanding it is $100 per share. Assuming a good partnership and EMA approval, I’d be glad to wait 2-3 years for a shot at that. Because I believe that the science will pan out.